Howard (Jack) West, MD

Howard Jack West, MD, Founder, Board President
Twitter Feed

GRACE - Global Resource for Advancing Cancer Education

GRACE - Global Resource for Advancing Cancer Education - 4616 25th Ave NE, # 300, Seattle, Washington 98105 - Rated 4.3 based on 15 Reviews "After a...

GRACE (@cancergrace) * Instagram photos and videos

108 Followers, 115 Following, 53 Posts - See Instagram photos and videos from GRACE (@cancergrace)

H. Jack West, MD, Founder and Past Board President; Vice President of Clinical Development at Summit Therapeutics
Summit Therapeutics
Menlo Park
CA
Specialties
Lung Cancer

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Dr. West received an M. Phil. in Experimental Biology from Cambridge University on a Fulbright Scholarship before returning to the US to undertake his medical training at Harvard Medical School in Boston, where he earned his MD magna cum laude and conducted research as a Howard Hughes Medical Student Fellow. He stayed in Boston for his internship and residency in internal medicine at Brigham and Women’s Hospital, then moved to Seattle, Washington for his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington. He joined Swedish Cancer Institute in Seattle in late 2002, where he directed the medical oncology component of the thoracic oncology program. He moved to City of Hope in 2019 to serve as an Associate Professor and build remote consult services for cancer patients around the world. In 2023, he transitioned to work as the Vice President of Clinical Development at Summit Therapeutics, where he focuses on efforts to advance novel treatments for lung cancer and other oncology settings to improve patient outcomes.

 

Dr. West maintains a strong clinical research focus on lung cancer and has authored dozens of peer-reviewed as well as invited publications. Over the past couple of decades, he has served as Web Editor for JAMA Oncology and a section editor and author for the lung cancer section of UpToDate while also developing a wide range of novel educational content across many platforms for other physicians, patients, and caregivers.

 


So What's New in Cancer Care?

Beacon Medical Interchange is a venture founded in 2016 by Dr. Jack West to facilitate communication of medical experts with industry leaders on the evolution of medical care trends in general and cancer management in particular.

Dr. David Spigel, Part 1: Clinical Research, Community Care (BMIC-074) - BeaconMedIC

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (24:32)  Download MP3 Audio Version

Conflict of Interest

President and Founder of OncTalk, LLC (intellectual property transferred to GRACE)

Vice President of Clinical Development at Summit Therapeutics

Consultant – AstraZeneca, Eli Lilly, Genentech, GenMab, OSI Pharmaceuticals sanofi-aventis; Center for Biomedical Continuing Education
Speakers Bureau – Eli Lilly, Genentech

Oncologists Dr. Jack West and Dr. Stephen Liu give an overview of both Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC), including treatment options for both disease types.

To listen to the complete Lung Cancer Video Library click here.

The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

In this video series, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss, and Dr. Ben Levy have continued candid discussions regarding cancer and COVID-19.

In this continued time of social distancing and limiting clinic exposure, the doctors sat down to virtually discuss some of the questions we all hear regarding these unprecedented times, and how they affect primarily cancer patients.

In this video, the discussion is surrounding the variable acceptance of the COVID19 vaccine. 

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered this past year (virtually) to review information presented at ASCO and ESMO 2021, regarding patients dealing with a Lung Cancer diagnosis.

For this series, the doctors discuss new trials for patients with NSCLC and SCLC.  The video discussions cover the following topics:

Forum Discussions

Original post date:

Just wanted to give a heads up to people who may be interested that the newest Ken Burns documentary is on the Story of Cancer, and it starts tonight. It'll be running on PBS over 3 nights.

You can

Last Activity: Fri, 03/29/2019 - 00:22
Original post date:

Dear all,

We don't do pop-ups or send lots of messages asking for support, but we do depend on your support to continue to offer our services at no cost. I do everything I do for GRACE with no pay

Last Activity: Fri, 03/29/2019 - 00:22
Original post date:

I just wanted to wish everyone who celebrates it a Merry Christmas!

-Dr. West

Last Activity: Fri, 03/29/2019 - 00:37
Original post date:

"CraigInPA" is our beloved and amazingly knowledgeable friend with a ROS1 rearrangement, who is a living testament to how insightful patients can become. He also highlights how patient communities can

Last Activity: Fri, 03/29/2019 - 00:22
Original post date:

Immunotherapy is causing an incredible buzz in the cancer world, so learn more about it in the setting of kidney cancer, melanoma, and lung cancer by coming to our patient forum with the leading

Last Activity: Fri, 03/29/2019 - 00:36

Comments

Post Date:

As for the weekly dosing of osimertinib, I've not seen this. We certainly did this for erlotinib 10

Post Date:

AbbyAnnie,

It's worth highlighting what is known and what is still unknown here. The role of the

Post Date:
Original Post: T790M finally detected

JojoS,

It is important to note that no test is perfectly sensitive at detecting a target all the

Post Date:

John,

I'm sorry to hear about what your wife and you have been going through. This sounds extremely

Post Date:

Carole,

These approaches haven't been directly compared, and it really depends on who can do the